# EDGAR Filing Document

**Accession Number:** 0001111928
**File Stem:** 0001111928-23-000018
**Filing Date:** 2023-2
**Character Count:** 31810
**Document Hash:** 9375dafc4fd91a490566bb961c95cc85
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001111928-23-000018.hdr.sgml**: 20230222

**ACCESSION NUMBER**: 0001111928-23-000018

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 13

**CONFORMED PERIOD OF REPORT**: 20230217

**ITEM INFORMATION**: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20230222

**DATE AS OF CHANGE**: 20230222

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** IPG PHOTONICS CORP
- **CENTRAL INDEX KEY:** 0001111928
- **STANDARD INDUSTRIAL CLASSIFICATION:** SEMICONDUCTORS & RELATED DEVICES [3674]
- **IRS NUMBER:** 043444218
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-33155
- **FILM NUMBER:** 23653783

**BUSINESS ADDRESS:**
- **STREET 1:** 377 SIMARANO DRIVE
- **CITY:** MARLBOROUGH
- **STATE:** MA
- **ZIP:** 01752
- **BUSINESS PHONE:** 5083731100

**MAIL ADDRESS:**
- **STREET 1:** 377 SIMARANO DRIVE
- **CITY:** MARLBOROUGH
- **STATE:** MA
- **ZIP:** 01752

?xml version="1.0" ? ipgp-20230217

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 8-K**

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934**

**February 17, 2023**

*Date of Report (Date of earliest event reported)*

**IPG PHOTONICS CORPORATION**

*(Exact name of registrant as specified in its charter)*

---

| | | |
|:---|:---|:---|
| **Delaware**<br>*(State or Other Jurisdiction*<br> *of Incorporation)* | **001-33155**<br>*(Commission File No.)* | **04-3444218**<br> *(IRS Employer*<br> *Identification No.)* |

---

**377 Simarano Drive**

**Marlborough, Massachusetts 01752**

*(Address of Principal Executive Offices, including Zip Code)*

(508) 373-1100

*(Registrant's telephone number)*

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol** | **Name of each exchange on which registered** |
| Common Stock, par value $0.0001 per share | IPGP | Nasdaq Global Select Market |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

**Item 5.02. Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers; Compensatory Arrangements of Principal Officers.**

**(e)** 

***Executive Compensation***

The Compensation Committee (the "<u>Committee</u>") of the Board of Directors (the "<u>Board</u>") of the Company and the Board took the actions described below relating to the compensation of the Company's named executive officers (as set forth in the Company's most recent proxy statement filed with the Securities and Exchange Commission) and certain other executive officers of the Company.

The Board recently approved the base salary, performance measures and target incentive payouts for 2023 as well as long term equity incentives for the CEO. The Committee approved the same for other executive officers of the Company. Base salary for Dr. Scherbakov, the CEO, increased 7.1% from 2022 and base salaries for the other named executive officers increased 3.5% from 2022 levels. The 2023 base salaries of the named executive officers are presented below:

---

| | | |
|:---|:---|:---|
| *Name* | *Base Salary 2022* | *Base Salary 2023* |
| Eugene Scherbakov, Ph.D. | €746,700 | €800,000 |
| Timothy P.V. Mammen | $520500 | $538700 |
| Angelo P. Lopresti | $469100 | $485500 |
| Alexander Ovtchinnikov, Ph.D. | $464700 | $481000 |
| Felix Stukalin | $454800 | $470700 |

---

&nbsp;&nbsp;&nbsp;&nbsp;

The approved annual targets and incentive payouts for the Company's named executive officers and other executive officers are governed by the Company's Senior Executive Annual Incentive Plan for fiscal year 2023 (the "<u>AIP</u>"). Consistent with prior years, the Committee identified two financial performance measures: net sales and adjusted EBIT (excluding equity-based compensation expenses, foreign currency transaction gains and losses and certain charges and write-downs), each as determined under the AIP, and assigned a 50% weighting factor to each financial performance goal. The Committee chose to focus on revenue and pretax profits so that our named executive officers and other executive officers would be incentivized to deliver the types of growth that benefit our stockholders, namely increasing sales and profits.

Under the 2023 AIP, the executive officers can receive cash incentive payments listed in the following table as a percentage of base salaries based upon achievement of the minimum to maximum objectives for both financial performance measures and for individual performance. Target bonuses as a percentage of salary remain the same as 2022 levels for the named executive officers. The 2023 AIP measures of the named executive officers are presented below:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| *Name* | *Name* | *Target (Financial plus Individual)*<sup>(1)</sup> | *Financial Performance Minimum*<sup>(1)</sup> | *Financial Performance Maximum*<sup>(1)</sup> | *Individual Performance Maximum*<sup>(1)</sup> | *Maximum Award Payout*<sup>(1)(2)</sup> |
| Eugene Scherbakov, Ph.D. | Eugene Scherbakov, Ph.D. | 110% | 41.25% | 220% | 27.50% | 247.50% |
| Timothy P.V. Mammen | Timothy P.V. Mammen | 80% | 30% | 160% | 20% | 180% |
| Angelo P. Lopresti | Angelo P. Lopresti | 80% | 30% | 160% | 20% | 180% |
| Alexander Ovtchinnikov, Ph.D. | Alexander Ovtchinnikov, Ph.D. | 80% | 30% | 160% | 20% | 180% |
| Felix Stukalin | Felix Stukalin | 80% | 30% | 160% | 20% | 180% |
| (1) | As a percentage of base salary. | As a percentage of base salary. | As a percentage of base salary. | As a percentage of base salary. | As a percentage of base salary. | As a percentage of base salary. |
| (2) | Maximum award payout is 225% of the target award (financial plus individual). | Maximum award payout is 225% of the target award (financial plus individual). | Maximum award payout is 225% of the target award (financial plus individual). | Maximum award payout is 225% of the target award (financial plus individual). | Maximum award payout is 225% of the target award (financial plus individual). | Maximum award payout is 225% of the target award (financial plus individual). |

---

The Committee may make adjustments under the AIP, including to our overall corporate performance goals, and the ways that our actual performance results are calculated that may cause differences between the numbers used for our performance goals and the numbers reported in our financial statements. The AIP authorizes the Committee to exercise

------

discretion to adjust or modify performance targets during a performance period for corporate transactions or any extraordinary item or event not foreseen at the time of the award, any unusual or non-recurrent event or economic condition that Committee deems not reflective of the Company's core operating performance or any other event that distorts the applicable performance targets. Also, the Committee may increase or reduce the amount of any award to reflect the Committee's assessment of a participant's individual performance during a performance period or for any other reason.

The Committee also approved grants of long-term incentives in the form of equity awards. The 2023 equity-based awards consist of service-based restricted stock units ("<u>RSUs</u>") weighted 50% and performance-based stock units ("<u>PSUs</u>") weighted 50%. The RSUs vest annually over three years on March 1, 2024, 2025 and 2026. The PSUs vest March 1, 2026, should any PSUs vest at all. Dividends, if any, on shares underlying the RSUs or PSUs do not vest until the stock units vest.

The Committee decided to weight the PSUs 50% on organic revenue growth and 50% on operating margin as detailed below. PSUs based upon revenue growth will vest based upon the Company's compound annual growth rate of organic revenue ("<u>Organic Revenue CAGR</u>") measured over a three-year performance period starting on January 1, 2023 and ending on December 31, 2025. The PSUs based upon operating margin will vest based upon the Company's average annual operating margin measured over the same performance period. Generally, organic revenue refers to the Company's total revenues excluding any impact from acquisitions and dispositions, and operating margin refers to a ratio, the numerator of which is the Company's operating income and the denominator of which is the Company's net sales. Operating income excludes equity-based compensation expenses, foreign currency transaction gains and losses, restructuring charges, legal settlements, employee-separation costs and product liability charges. The Committee set a target, threshold and maximum for each performance metric. Performance below the target would decrease the award, subject to a minimum performance level below which no PSUs would be earned, and performance above the target would increase the award, subject to a maximum cap of 200% of the respective target award. If the minimum performance level is reached on the Organic Revenue CAGR measure, payout is further conditioned on attainment of minimum operating margin over the performance period. Otherwise, payment for each performance measures is not dependent upon attaining the minimum for the other performance measure. The Committee has the authority to exercise discretion to change the performance goals described or the actual payout, in whole or in part, as it deems appropriate and equitable to reflect a change in the business, operations, corporate structure or capital structure of the Company or its affiliates, the manner in which it conducts its business, or other events or circumstances that Committee deems not reflective of the Company's core operating performance or any other event that distorts the applicable performance targets.

The following table lists the RSUs and PSUs awarded to the named executive officers:

---

| | | | |
|:---|:---|:---|:---|
| *Name* | *Service-Based Restricted Stock* | *Performance Stock Units on Organic Revenue CAGR* | *Performance Stock Units on Operating Margin* |
| Eugene Scherbakov, Ph.D. | 16837 | 8418 | 8418 |
| Timothy P.V. Mammen | 6160 | 3080 | 3080 |
| Angelo P. Lopresti | 5089 | 2544 | 2544 |
| Alexander Ovtchinnikov, Ph.D. | 5042 | 2521 | 2521 |
| Felix Stukalin | 5077 | 2538 | 2538 |

---

***Non-Employee Director Compensation Plan***

Effective February 17, 2023, the Board approved amending the IPG Photonics Corporation Non-Employee Director Compensation Plan (the "<u>Director Compensation Plan</u>") to increase the annual retainer for the non-executive Chair from $70,000 to $80,000.

The foregoing description of the Director Compensation Plan, as amended, does not purport to be complete and is qualified in its entirety by reference to the Directors Compensation Plan, as amended, a copy of which is attached as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated herein by reference.

**Item 9.01. Financial Statements and Exhibits**

(d) Exhibits

------

---

| | |
|:---|:---|
| **Exhibit Number** | **Exhibit Description** |
| Exhibit 10.1 | <u>[IPG Photonics Corporation Non-Employee Director Compensation Plan](ipgphotonicscorporationnon.htm)</u> |

---

------

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this Current Report on Form 8-K to be signed on its behalf by the undersigned thereunto duly authorized.

---

| | | |
|:---|:---|:---|
| | **IPG PHOTONICS CORPORATION** | **IPG PHOTONICS CORPORATION** |
| February 22, 2023 | By: | /s/ Angelo P. Lopresti |
|  |  | Angelo P. Lopresti |
|  |  | Senior Vice President, General Counsel & Secretary |

---

## Exhibit 10.1

***Exhibit 10.1***

**IPG PHOTONICS CORPORATION**

**<u>NON-EMPLOYEE DIRECTOR COMPENSATION PLAN</u>**

As Amended and Restated, effective February 17, 2023

**Article 1.&nbsp;&nbsp;&nbsp;&nbsp;Establishment, Objectives and Duration**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**1.1&nbsp;&nbsp;&nbsp;&nbsp;Amendment and Restatement of Plan.** IPG Photonics Corporation, a Delaware corporation (the "<u>Company</u>"), hereby amends and restates the compensation plan for Non-Employee Directors known as the "IPG Photonics Corporation Non-Employee Director Compensation Plan" (the "<u>Plan</u>").

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**1.2&nbsp;&nbsp;&nbsp;&nbsp;Plan Objectives.** The objectives of the Plan are to give the Company an advantage in attracting and retaining Non-Employee Directors and to link the interests of Non-Employee Directors to those of the Company's stockholders.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**1.3&nbsp;&nbsp;&nbsp;&nbsp;Duration of the Plan.** The Plan commenced on June 21, 2006 and will remain in effect until the Board of Directors terminates it pursuant to Section 6.2.

**Article 2.&nbsp;&nbsp;&nbsp;&nbsp;Definitions**

The following defined terms have the meanings set forth below:

**"Affiliate"** means any person that, directly or indirectly, is in control of, is controlled by, or is under common control with, the Company.

**"Annual Retainer"** means the retainer fee established by the Board in accordance with Section 5.1 and paid to a Non-Employee Director for services performed as a member of the Board of Directors for a 12-month period.

**"Board"** or **"Board of Directors"** means the Board of Directors of the Company.

**"Code"** means the Internal Revenue Code of 1986, as amended.

**"Committee Meeting Fee"** means any fee established by the Board in accordance with Section 5.1 and paid to a Non-Employee Director for each attendance at a meeting of a Board committee (including telephonic meetings but excluding execution of unanimous written consents).

 **"Company"** means IPG Photonics Corporation, a Delaware corporation, and any successor thereto as provided in Section 6.4.

**"Director"** means any individual who is a member of the Board of Directors.

**"Effective Date"** has the meaning ascribed to it in Section 6.1.

**"Exchange Act"** means the Securities Exchange Act of 1934, as amended from time to time, or any successor to it.

**"Installment Payment"** has the meaning ascribed to it in Section 5.1.

**"Meeting Fee"** means any fee established by the Board in accordance with Section 5.1 and paid to a Non-Employee Director for each attendance at a meeting of the Board of Directors (including telephonic meetings but excluding execution of unanimous written consents).

**"Non-Employee Director"** means a Director who, at the time in question, is not an employee of the Company or any of its Affiliates.

------

**"Non-Executive Chair"** means the Non-Employee Director selected by the Board as the Non-Executive Chair in accordance with the By-Laws of the Company, if any.

**"Plan"** has the meaning ascribed to it in Section 1.1.

**"Lead Independent Director"** means the Non-Employee Director selected by the other Non-Employee Directors as the lead independent Director, if any, at meetings of the Non-Employee Directors held in accordance with applicable rules of any securities exchange on which the Company's securities are listed.

**"Retirement"** means a Director's Separation from Service upon or after serving eight full years as a Director.

**"Separation from Service"** or "Separate from Service" means ceasing to be a Director of the Company for any reason. Notwithstanding anything to the contrary, the determination of whether an individual has had a Separation from Service will be made in accordance with Code Section 409A and the regulations thereunder.

**"Shares"** means the shares of common stock of the Company with a par value of $0.0001 per share.

**Article 3.&nbsp;&nbsp;&nbsp;&nbsp;Administration**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**3.1&nbsp;&nbsp;&nbsp;&nbsp;The Board of Directors.** The Plan will be administered by the Board of Directors. The Board of Directors will act by a majority of its members at the time in office and eligible to vote on any particular matter, and may act either by a vote at a meeting or in writing without a meeting.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**3.2&nbsp;&nbsp;&nbsp;&nbsp;Authority of the Board of Directors.** Except as limited by law and subject to the provisions herein, the Board of Directors has full power to: construe and interpret the Plan and any agreement or instrument entered into under the Plan; establish, amend or waive rules and regulations for the Plan's administration; and amend the terms and conditions of the Plan. Further, the Board of Directors will make all other determinations that may be necessary or advisable for the administration of the Plan. As permitted by law and consistent with Section 3.1, the Board of Directors may delegate some or all of its authority under this Plan. The Compensation Committee, under its Charter, will make recommendations to the Board regarding this Plan.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**3.3&nbsp;&nbsp;&nbsp;&nbsp;Decisions Binding.** All determinations and decisions made by the Board of Directors pursuant to the provisions of the Plan will be final, conclusive, and binding on all persons, including the Company, its stockholders, all Affiliates, Non-Employee Directors and their estates and beneficiaries.

**Article 4.&nbsp;&nbsp;&nbsp;&nbsp;Eligibility**

Each Non-Employee Director of the Board will participate in the Plan while such person is a Non-Employee Director.

**Article 5.&nbsp;&nbsp;&nbsp;&nbsp;Non-Employee Director Compensation**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**5.1&nbsp;&nbsp;&nbsp;&nbsp;Cash Annual Retainer.** Each Non-Employee Director will be entitled to receive an Annual Retainer in the amount determined from time to time by the Board. Until changed by resolution of the Board of Directors, the Annual Retainer will be $40,000 for each Non-Employee Director. In addition to the Annual Retainer paid to each Non-Employee Director, the following additional Annual Retainers shall be paid for additional service(s) of a Non-Employee Director: (i) $25,000 for the chair of the Audit Committee and $12,500 for all other members of

------

the Audit Committee, (ii) $22,500 for the chair of the Compensation Committee and $10,000 for all other members of the Compensation Committee, (iii) $17,500 for the chair of the Nominating & Corporate Governance Committee and $7,500 for all other members of the Nominating & Corporate Governance Committee, (iv) $80,000 for the Non-Executive Chair and (v) $30,000 for the Lead Independent Director.

The Annual Retainer will be paid in monthly cash installments (the "<u>Installment Payments</u>") to the Non-Employee Director, normally payable not later than the last business day of the month preceding the month to which the installment applies. Each Installment Payment to a Non-Employee Director will equal the quotient of the Non-Employee Director's Annual Retainer divided by twelve, prorated as necessary to account for partial months of service on the Board.

Unless changed by resolution of the Board of Directors, no Meeting Fees or Committee Meeting Fees will be paid to Non-Employee Directors. Committee Meeting Fees for meetings of any special committee of the Board, if any, will be established at the time the Board establishes such committee.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**5.2&nbsp;&nbsp;&nbsp;&nbsp;Equity Grants.** Each Non-Employee Director will be entitled to receive the following equity grants, subject to the terms of the applicable award agreements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;<u>Initial Equity Grants</u>. As of the date of an annual stockholder meeting of the Company at which an individual is elected by the stockholders to serve as a Non-Employee Director or as of the date on which an individual is appointed by the Board of Directors to serve as a Non-Employee Director, such Non-Employee Director will receive, subject to Board approval, equity grants in accordance with the following terms:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (i)&nbsp;&nbsp;&nbsp;&nbsp;Restricted stock units with an initial grant date fair market value of $250,000 (calculated using the closing price of a Share on the grant date and rounded down to the next whole Share), which will vest on the first anniversary of the grant date, subject to the Non-Employee Director's continued service on the Board on the vesting date.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;&nbsp;&nbsp;&nbsp;The grant date for equity grants described in this Section 5.2(a) will be the date specified in the resolution passed by the Board.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;<u>Annual Equity Grants to Continuing Directors</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;&nbsp;&nbsp;&nbsp;Subject to (ii) below, as of the date of any annual stockholder meeting of the Company at which such Non-Employee Director is re-elected to serve in such position, such Non-Employee Director will receive equity grants in accordance with the following terms (unless changed by resolution of the Board of Directors or as otherwise specified in an award agreement):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (A)&nbsp;&nbsp;&nbsp;&nbsp;Restricted stock units with an initial grant date fair market value of $250,000 (calculated using the closing price of a Share on the grant date and rounded down to the next whole Share), which will vest, subject to the Non-Employee Director's continued service on the Board, upon the earlier to occur of (I) the first anniversary of the grant date or (II) the date of the next annual stockholder meeting.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(B)&nbsp;&nbsp;&nbsp;&nbsp;The grant date for equity grants described in this Section 5.2(b)(i) will be the date of the annual meeting of stockholders at which a Non-Employee Director is re-elected.

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;&nbsp;&nbsp;&nbsp;Newly-elected Non-Employee Directors who begin providing services to the Board as of any annual stockholder meeting of the Company are not eligible to receive the annual equity grants described in (i) above at such annual meeting. Newly-elected Non-Employee Directors who are elected as of a date prior to the date of any annual stockholder meeting of the Company will receive a portion of the annual equity grants described in (i) above, prorated quarterly, in accordance with the following schedule:

---

| | |
|:---|:---|
| **Number of Days between Election Date and Annual Shareholder Meeting Date** | **Annual Equity Grant Payable at Subsequent Annual Meeting** |
| 1 - 60 days | 0% |
| 61 - 120 days | 25% |
| 121 - 180 days | 50% |
| 181 - 270 days | 75% |
| 271 - 364 days | 100% |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;&nbsp;&nbsp;<u>Separation from Service; Retirement</u>. Non-Employee Directors will forfeit any unvested equity awards upon any Separation from Service, and any vested stock options will be treated as provided in the applicable award agreement. Notwithstanding the foregoing, a Non-Employee Director who terminates his or her Board service due to Retirement will receive immediate vesting of all unvested equity awards as of the date of such Separation from Service and any vested stock options will remain exercisable for 90 days following the date of such Separation from Service.

**Article 6.&nbsp;&nbsp;&nbsp;&nbsp;Miscellaneous**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**6.1&nbsp;&nbsp;&nbsp;&nbsp;Effective Date.** This amended and restated Plan is effective as of February 17, 2023 (the "<u>Effective Date</u>") and will remain in effect as provided in Section 1.3 hereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**6.2&nbsp;&nbsp;&nbsp;&nbsp;Modification and Termination.** The Board may at any time and from time to time, alter, amend, modify, or terminate the Plan in whole or in part.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**6.3&nbsp;&nbsp;&nbsp;&nbsp;Indemnification.** Each person who is or has been a member of the Board will be indemnified and held harmless by the Company against and from any loss, cost, liability, or expense that may be imposed upon or reasonably incurred by that person in connection with or resulting from any claim, action, suit, or proceeding to which that person may be a party or in which that person may be involved by reason of any action taken or failure to act under the Plan and against and from any and all amounts paid by that person in a settlement approved by the Company, or paid by that person in satisfaction of any judgment in any such action, suit, or proceeding against that person, provided he or she gives the Company an opportunity, at its own expense, to handle and defend the action, suit or proceeding before that person undertakes to handle and defend it. The foregoing right of indemnification will not be exclusive of any other rights of indemnification to which an individual may be entitled under the Company's Certificate of Incorporation or By-laws, each as may be amended from time to time, as a matter of law, or otherwise, or any power that the Company may have to indemnify him or her or hold him or her harmless.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**6.4&nbsp;&nbsp;&nbsp;&nbsp;Successors.** All obligations of the Company under the Plan will be binding on any successor to the Company, whether the existence of the successor is the result of a direct or

------

indirect purchase of all or substantially all of the business and/or assets of the Company, or a merger, consolidation, or otherwise.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**6.5&nbsp;&nbsp;&nbsp;&nbsp;Reservation of Rights.** Nothing in this Plan or in any award agreement granted hereunder will be construed to limit in any way the Board's right to remove a Non-Employee Director from the Board.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**6.6**&nbsp;&nbsp;&nbsp;&nbsp;**Compensation Recovery Policy**. Notwithstanding any provision in the Plan to the contrary, the payments, benefits, and equity grants described in this Plan will be subject to any Compensation Recovery Policy established by the Company, as may be amended from time to time.

**Article 7.&nbsp;&nbsp;&nbsp;&nbsp;Legal Construction**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**7.1&nbsp;&nbsp;&nbsp;&nbsp;Gender and Number.** Except where otherwise indicated by the context, any masculine term used herein will also include the feminine; the plural will include the singular and the singular will include the plural.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**7.2&nbsp;&nbsp;&nbsp;&nbsp;Severability.** If any provision of the Plan is held illegal or invalid for any reason, the illegality or invalidity will not affect the remaining parts of the Plan, and the Plan will be construed and enforced as if the illegal or invalid provision had not been included.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**7.3&nbsp;&nbsp;&nbsp;&nbsp;Requirements of Law.** The issuance of payments under the Plan will be subject to all applicable laws, rules, and regulations, and to any approvals required by any governmental agencies or national securities exchanges.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**7.4&nbsp;&nbsp;&nbsp;&nbsp;Securities Law and Tax Law Compliance.** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;**Insider Trading.** To the extent any provision of the Plan or action by the Board would subject any Non-Employee Director to liability under Section 16(b) of the Exchange Act, it will be deemed null and void, to the extent permitted by law and deemed advisable by the Board.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;**Section 409A.** This Plan is intended to be exempt from or to comply with Code Section 409A and the regulations thereunder, and will be administered and interpreted in accordance with such intent. If the Company determines that any provision of the Plan is or might be inconsistent with the requirements of Code Section 409A, it will attempt in good faith to make such changes to the Plan as may be necessary or appropriate to avoiding a Non-Employee Director's becoming subject to adverse tax consequences under Code Section 409A. No provision of the Plan will be interpreted to transfer any liability for a failure to comply with Code Section 409A from a Non-Employee Director or any other individual to the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**7.5&nbsp;&nbsp;&nbsp;&nbsp;Governing Law.** The Plan will be construed in accordance with and governed by the laws of the Commonwealth of Massachusetts, determined without regard to its conflict of law rules. The jurisdiction and venue for any disputes arising under, or any action brought to enforce (or otherwise relating to), this Plan will be exclusively in the Superior Court of the Commonwealth of Massachusetts and the United States District Court for the District of Massachusetts, Worcester Division.

<br>